Incidence of acute oral sequelae in pediatric patients undergoing chemotherapy

Pediatric Dentistry

Volumn 31, Issue 5, 2009, Pages 420-425

  Hong, C H ^a,b   Brennan, M T ^b   Lockhart, P B ^b  

^a Department of Pediatric Dentistry ^*

^b CAROLINAS MEDICAL CENTER   (United States)

Author keywords

Drug therapy; Oral manifestations; Pediatric dentistry

Indexed keywords

ANTINEOPLASTIC AGENT; MYELOABLATIVE AGENT;

ACUTE DISEASE; ADOLESCENT; ADULT; CHEMICALLY INDUCED DISORDER; CHILD; HUMAN; INFANT; MOUTH DISEASE; NEOPLASM; PRESCHOOL CHILD; REVIEW;

ACUTE DISEASE; ADOLESCENT; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; MOUTH DISEASES; MYELOABLATIVE AGONISTS; NEOPLASMS; YOUNG ADULT;

EID: 70350434540     PISSN: 01641263     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ. Patient reports of complications of bone marrow transplantation. Support Care Cancer 2000;8:33-9.
2. Sonis ST, Sonis AL, Lieberman A. Oral complications in patients receiving treatment for malignancies other than of the head and neck. J Am Dent Assoc 1978;97: 468-72.
3. Sonis S, Kunz A. Impact of improved dental services on the frequency of oral complications of cancer therapy for patients with nonhead-and-neck malignancies. Oral Surg Oral Med Oral Pathol 1988;65: 19-22.
4. Van Spall HG, Toren A, Kiss A, Fowler RA. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: A systematic sampling review. JAMA 2007;297:1233-40.
5. Berkowitz RJ, Strandjord S, Jones P, et al. Stomatologic complications of bone marrow transplantation in a pediatric population. Pediatr Dent 1987;9:105-10.
6. Childers NK, Stinnett EA, Wheeler P, Wright JT, Castleberry RP, Dasanayake AP. Oral complications in children with cancer. Oral Surg Oral Med Oral Pathol 1993;75:41-7.
7. Dahllof G, Heimdahl A, Modeer T, Twetman S, Bolme P, Ringden O. Oral mucous membrane lesions in children treated with bone marrow transplantation. Scand J Dent Res 1989;97:268-77.
8. Fayle SA, Curzon MEJ. Oral complications in pediatric oncology patients. Pediatr Dent 1991; 13:289-95.
9. Kamp AA. Neoplastic diseases in a pediatric population: A survey of the incidence of oral complications. Pediatr Dent 1988;10:25-9.
10. Sonis A, Sonis S. Oral complications of cancer chemotherapy in pediatric patients. J Pedod 1979;3: 122-8.
11. Williams MC, Martin MV. A longitudinal study of the effects on the oral mucosa of treatment for acute childhood leukaemia. Int J Paediatr Dent 1992;2:73-9.
12. Chen CF, Wang RH, Cheng SN, Chang YC. Assessment of chemotherapy-induced oral complications in children with cancer. J Pediatr Oncol Nurs 2004;21:33-9.
13. Niehaus CS, Meiller TF, Peterson DE, Overholser CD. Oral complications in children during cancer therapy. Cancer Nurs 1987;10:15-20.
14. Bonnaure-Mallet M, Bunetel L, Tricot-Doleux S, Guerin J, Bergeron C, LeGall E. Oral complications during treatment of malignant diseases in childhood: Effects of tooth-brushing. Eur J Cancer 1998;34: 1588-91.
15. Cheng KK, Molassiotis A, Chang AM, Wai WC, Cheung SS. Evaluation of an oral care protocol intervention in the prevention of chemotherapy-induced oral mucositis in paediatric cancer patients. Eur J Cancer 2001; 37:2056-63.
16. Pereira Pinto L., de Souza LB, Gordon-Nunez MA, et al. Prevention of oral lesions in children with acute lymphoblastic leukemia. Int J Pediatr Otorhinolaryngol 2006;70: 1847-51.
17. Levy-Polack MP, Sebelli P, Polack NL. Incidence of oral complications and application of a preventive protocol in children with acute leukemia. Spec Care Dentist 1998; 18:189-93.
18. Lucas VS, Roberts GJ, Beighton D. Oral health of children undergoing allogeneic bone marrow trans-plantation. Bone Marrow Transplant 1998;22:801-8.
19. Costa EM, Fernandes MZ, Quinder LB, de Souza LB, Pinto LP. Evaluation of an oral preventive protocol in children with acute lymphoblastic leukemia. Pesqui Odontol Bras 2003;17:147-50.
20. Drummond BK. Oral problems in children with malignancy. N Z Dent J 1992;88:64.
21. Baliga AM, Brave VR, Vyas HA. Oral mucosal lesions in patients with acute leukemias and related disorders due to cytotoxic therapy. J Indian Soc Pedod Prev Dent 1995;13:25-9.
22. Holmes S. The oral complications of specific anticancer therapy. Int J Nurs Stud 1991;28:343-60.
23. Avritscher EB, Cooksley CD, Elting LS. Scope and epidemiology of cancer therapy-induced oral and gastrointestinal mucositis. Semin Oncol Nurs 2004;20: 3-10.
24. Ramirez-Amador V, Esquivel-Pedraza L, Mohar A, et al. Chemotherapy-associated oral mucosal lesions in patients with leukaemia or lymphoma. Eur J Cancer B Oral Oncol 1996;32B:322-7.
25. Dreizen S, McCredie KB, Bodey GP, Keating MJ. Quantitative analysis of the oral complications of antileukemia chemotherapy. Oral Surg Oral Med Oral Pathol 1986;62:650-3.
26. Sonic ST, Elting LS, Keefe D, et al. Perspectives on cancer therapy-induced mucosal injury: Pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 2004;100:1995-2025.
27. Wardley AM, Jayson GC, Swindell R, et al. Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue. Br J Haematol 2000;110:292-9.
28. Robien K, Schubert MM, Bruemmer B, Lloid ME, Potter JD, Ulrich CM. Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia. J Clin Oncol 2004; 22:1268-75.
29. Keefe DM, Peterson DE, Schubert MM. Developing evidence-based guidelines for management of alimentary mucositis: Process and pitfalls. Support Care Cancer 2006; 14:492-8.
30. Schubert MM, Peterson DE, Flournoy N, Meyers JD, Truelove EL. Oral and pharyngeal herpes simplex virus infection after allogeneic bone marrow transplantation: Analysis of factors associated with infection. Oral Surg Oral Med Oral Pathol 1990;7:286-93.